Long-term continuous subcutaneous treprostinil therapy for pulmonary arterial hypertension

被引：0
|
作者：
Skoro-Sajer, N
Harja, E
Bonderman, D
Rezaie-Majd, S
Machherndl, S
Kneussl, M
Lang, MI
机构：
[1] Dept Internal Med 2, Vienna, Austria
[2] Dept Internal Med 4, Vienna, Austria
来源：
EUROPEAN HEART JOURNAL | 2003年 / 24卷
关键词：
D O I：
10.1016/S0195-668X(03)95424-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：483 / 483
页数：1
相关论文
共 50 条
  • [1] Long-term subcutaneous treprostinil (Remodulin) therapy for severe pulmonary arterial hypertension
    Skoro-Sajer, N.
    Bonderman, D.
    Harja, E.
    Jakowitsch, J.
    Maurer, G.
    Kneussl, M.
    Lang, I. M.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 79 - 79
  • [2] Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension
    Lang, Irene
    Gomez-Sanchez, Miguel
    Kneussl, Meinhard
    Naeije, Robert
    Escribano, Pilar
    Skoro-Sajer, Nika
    Vachiery, Jean-Luc
    [J]. CHEST, 2006, 129 (06) : 1636 - 1643
  • [3] Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
    Barst, R. J.
    Galie, N.
    Naeije, R.
    Simonneau, G.
    Jeffs, R.
    Arneson, C.
    Rubin, L. J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (06) : 1195 - 1203
  • [4] Combination Therapy For Pulmonary Arterial Hypertension With Oral Treprostinil: Long-Term Follow Up
    Ruggiero, R. M.
    Bartolome, S.
    Chin, K. M.
    Torres, F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [5] Long-term subcutaneous treprostinil therapy evokes both survival benefits and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension
    Vachiery, JL
    Gautier, MT
    Huez, S
    Retailleau, K
    Naeije, R
    [J]. CIRCULATION, 2003, 108 (17) : 400 - 400
  • [6] USE OF SUBCUTANEOUS TREPROSTINIL IN PEDIATRIC PULMONARY ARTERIAL HYPERTENSION - BRIDGE-TO-TRANSPLANT OR LONG-TERM TREATMENT?
    Ablonczy, L.
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 : 11 - 11
  • [7] Subcutaneous treprostinil therapy in pulmonary arterial hypertension due to congenital heart diseases - A long term multicentre analysis
    Vachiery, JL
    Pavelescu, A
    Lang, IM
    Skoro, N
    Gomez-Sanchez, MA
    Escribano, P
    Naeije, R
    [J]. CIRCULATION, 2005, 112 (17) : U480 - U481
  • [8] Long-term experience with implantable treprostinil pumps in pulmonary arterial hypertension
    Dytrych, V
    Kuchar, J.
    Ambroz, D.
    Kunstyr, J.
    Grus, T.
    Lindner, J.
    Linhart, A.
    Jansa, P.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (05): : 358 - 361
  • [9] Tolerability and Efficacy of Subcutaneous Treprostinil Therapy in Patients with Pulmonary Arterial Hypertension
    Hatano, Masaru
    Maki, Hisataka
    Minatsuki, Shun
    Komuro, Issei
    [J]. JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S193 - S193
  • [10] Long-term treatment of pulmonary arterial hypertension with treprostinil: Echocardiographic evaluation of efficacy
    Zwicke, D
    Lobacz, D
    Johnson, L
    Wade, M
    Roscigno, R
    [J]. CHEST, 2003, 124 (04) : 89S - 89S
12345